Price T Rowe Associates Inc Harmony Biosciences Holdings, Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$401 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$209 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$124 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$93.2 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$68.9 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.12B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...